Trial intelligence / Profile preview

POLET: Staloral in Grass Pollen Allergic Rhinoconjunctivitis

NCT01785394Phase 4Unknown

Start
Feb 2012
Primary completion
Oct 2013
Modality
Allergy Immunotherapy
Countries
1
01

Overview

A Phase 4 trial of dermatophagoides pteronyssinus extract in allergic rhinoconjunctivitis (ARC). Status: unknown.

02

Drugs

dermatophagoides pteronyssinus extract
03

Conditions

allergic rhinoconjunctivitis (ARC)

Beyond the preview

Go deeper on NCT01785394.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01785394.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call